ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      AI Subscribe Login/Register Profile Icon
      S&P 500
      6,049.88
      0.05%
      US Tech 100
      20,674.80
      0.00%
      Dow Jones
      44,705.53
      -0.17%
      Brent Oil
      73.66
      0.07%
      Bitcoin
      96,783.70
      0.85%
      Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ

      6. Arcutis Biotherapeutics Inc (ARQT) Quote

      Arcutis Biotherapeutics Inc

      Arcutis Biotherapeutics Inc (ARQT)

      NASDAQ
      12.27
      0.00
      (0.00%)
      Closed December 04 4:00PM
      Delayed by 15 minutes
      0.00
      0.00
      (0.00%)
      After Hours: -
      Delayed by 15 minutes

      Your Hub for Real-Time streaming quotes, Ideas and Live Discussions

      Premium

      Key stats and details

      Current Price
      12.27
      Bid
      12.28
      Ask
      12.45
      Volume
      -
      0.00 Day's Range 0.00
      1.89 52 Week Range 13.50
      Market Cap
      1.436B
      Previous Close
      12.27
      Open
      -
      Last Trade
      Last Trade Time
      Financial Volume
      -
      VWAP
      -
      Average Volume (3m)
      2,011,765
      Shares Outstanding
      117,044,591
      Dividend Yield
      -
      PE Ratio
      -5.48
      Earnings Per Share (EPS)
      -2.24
      Revenue
      59.61M
      Net Profit
      -262.14M

      About Arcutis Biotherapeutics Inc

      Arcutis Biotherapeutics Inc is a medical dermatology company. It is developing treatments for patients with immune-mediated dermatological diseases and conditions. It is leveraging recent advances in immunology and inflammation to develop differentiated therapies against biologically validated targe... Arcutis Biotherapeutics Inc is a medical dermatology company. It is developing treatments for patients with immune-mediated dermatological diseases and conditions. It is leveraging recent advances in immunology and inflammation to develop differentiated therapies against biologically validated targets to solve persistent treatment challenges in serious diseases of the skin. The company's lead product candidate, roflumilast cream, has successfully completed pivotal Phase 3 clinical trials in plaque psoriasis, demonstrating symptomatic improvement and favorable tolerability in this population. Show more

      Sector
      Pharmaceutical Preparations
      Industry
      Pharmaceutical Preparations
      Website
      www.arcutis.com
      Headquarters
      Wilmington, Delaware, USA
      Founded
      -
      Arcutis Biotherapeutics Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker ARQT. The last closing price for Arcutis Biotherapeutics was $12.27. Over the last year, Arcutis Biotherapeutics shares have traded in a share price range of $ 1.89 to $ 13.50.

      Arcutis Biotherapeutics currently has 117,044,591 shares outstanding. The market capitalization of Arcutis Biotherapeutics is $1.44 billion. Arcutis Biotherapeutics has a price to earnings ratio (PE ratio) of -5.48.

      Ask ADVFN Intelligence (AI)

      Arcutis Biotherapeutics (ARQT) Options Flow Summary

      ARQT Options Flow

      Overall Flow

      Bullish

      Net Premium

      59k

      Calls / Puts

      100.00%

      Buys / Sells

      100.00%

      OTM / ITM

      0.00%

      Sweeps Ratio

      0.00%

      ARQT Latest News

      More News

      Form 4 - Statement of changes in beneficial ownership of securities

      11 hours ago
      Edgar (US Regulatory)

      Form 4 - Statement of changes in beneficial ownership of securities

      11 hours ago
      Edgar (US Regulatory)

      Form 4 - Statement of changes in beneficial ownership of securities

      11 hours ago
      Edgar (US Regulatory)

      Form 4 - Statement of changes in beneficial ownership of securities

      11 hours ago
      Edgar (US Regulatory)

      Arcutis Announces Promotions on Executive Management Team

      Strategic appointments support further growth and position Company for future success WESTLAKE VILLAGE, Calif., Dec. 03, 2024 (GLOBE NEWSWIRE) -- Arcutis Biotherapeutics, Inc. (Nasdaq: ARQT), a...

      20 hours ago
      GlobeNewswire Inc.

      Form 144 - Report of proposed sale of securities

      December 02 2024
      Edgar (US Regulatory)

      Form 4 - Statement of changes in beneficial ownership of securities

      November 19 2024
      Edgar (US Regulatory)

      Form 144 - Report of proposed sale of securities

      November 19 2024
      Edgar (US Regulatory)

      Arcutis’ ZORYVE® (roflumilast) Awarded Best Eczema Treatment by Glamour

      ZORYVE cream 0.15% is the first once-daily, Food and Drug Administration (FDA)-approved topical treatment for mild to moderate atopic dermatitisZORYVE, a next-generation topical...

      November 13 2024
      GlobeNewswire Inc.

      Form 10-Q - Quarterly report [Sections 13 or 15(d)]

      November 06 2024
      Edgar (US Regulatory)
      PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
      10.675.7758620689711.613.511.38206316812.43837955CS
      42.930.94983991469.3713.58.9235003810.65815592CS
      121.5114.033457249110.7613.58.0320117659.92324059CS
      264.2753.375813.56.9922209559.64310092CS
      5210.28516.5829145731.9913.51.8934732787.67438252CS
      156-2.85-18.849206349215.1227.41.7617893098.84257794CS
      260-10.78-46.767895878523.0540.881.7611730759.9561656CS

      Movers

      View all
      • Most Active
      • % Gainers
      • % Losers
      SymbolPriceVol.
      AALAmerican Airlines Group Inc
      $ 14.47
      (0.00%)
      		0
      AAGRAfrican Agriculture Holdings Inc
      $ 0.1326
      (0.00%)
      		0
      AADRAdvisorShares Dorsey Wright ADR ETF
      $ 69.03
      (0.00%)
      		0
      AADIAadi Bioscience Inc
      $ 2.48
      (0.00%)
      		0
      AACGATA Creativity Global
      $ 0.9752
      (0.00%)
      		0
      AALAmerican Airlines Group Inc
      $ 14.47
      (0.00%)
      		0
      AAGRAfrican Agriculture Holdings Inc
      $ 0.1326
      (0.00%)
      		0
      AADRAdvisorShares Dorsey Wright ADR ETF
      $ 69.03
      (0.00%)
      		0
      AADIAadi Bioscience Inc
      $ 2.48
      (0.00%)
      		0
      AACGATA Creativity Global
      $ 0.9752
      (0.00%)
      		0
      AALAmerican Airlines Group Inc
      $ 14.47
      (0.00%)
      		0
      AAGRAfrican Agriculture Holdings Inc
      $ 0.1326
      (0.00%)
      		0
      AADRAdvisorShares Dorsey Wright ADR ETF
      $ 69.03
      (0.00%)
      		0
      AADIAadi Bioscience Inc
      $ 2.48
      (0.00%)
      		0
      AACGATA Creativity Global
      $ 0.9752
      (0.00%)
      		0

      ARQT Discussion

      View Posts
      Monksdream Monksdream 3 months ago
      ARQT under $15
      👍️0
      52172 52172 3 months ago
      Ath’s incoming
      👍️0
      52172 52172 3 months ago
      Put the crackpipe down
      👍️0
      52172 52172 3 months ago
      Wrong we beat big time sucka
      👍️0
      52172 52172 3 months ago
      12 coming
      👍️0
      Sierra20 Sierra20 4 months ago
      $6 coming
      👍️0
      Sierra20 Sierra20 4 months ago
      Earnings missed big time and this tanks hard
      👍️0
      52172 52172 5 months ago
      Not yet need 20’s which will come
      👍️ 1
      MiamiGent MiamiGent 5 months ago
      ARQT $10.82 HOD!
      Everybody happy?
      👍️0
      52172 52172 5 months ago
      Some large transactions happening a sign of whats to come
      👍️ 1
      52172 52172 5 months ago
      Gonna close green watch
      👍️0
      MiamiGent MiamiGent 5 months ago
      ARQT The short interest is about 25%
      The free trading float is tiny.
      Share Price should rise steadily today.
      👍️0
      MiamiGent MiamiGent 5 months ago
      ARQT $10.69 last pre-mkt buy, up .67 from yesterday's close.
      Steadily rising, as I expected.

      The mkt for this FDA approved medicine (last night) is reportedly multi- billions of dollars.
      👍️0
      52172 52172 5 months ago
      Im hoping!
      👍️0
      MiamiGent MiamiGent 5 months ago
      ARQT Needham Reiterates BUY on Arcutis Biotherapeutics, maintains $18 Price Target

      6:28 AM this morning
      👍️0
      MiamiGent MiamiGent 5 months ago
      ARQT That's right. The market for this is reportedly three times larger than the previous approved candidate- and that one grew about 250% last qtr.
      AND, Arcutis (ARQT) will roll out this new medicine by the end of THIS MONTH.

      I am going to buy this product- I have psoriasis all over, except my face thank God.
      👍️0
      52172 52172 5 months ago
      Real revenue is gonna begin to come in.
      👍️0
      52172 52172 5 months ago
      Headed to 20’s soon enough!
      👍️0
      MiamiGent MiamiGent 5 months ago
      $ARQT HUge short interest, next to no free float and FDA Approval tonight for a BIG MARKET drug.
      The boys will run this tomorrow.
      👍️0
      MiamiGent MiamiGent 5 months ago
      $ARQT
      Arcutis Biotherapeutics Inc

      My guess it'll be $11 by 8PM.
      The real fun starts in Pre-Market, tomorrow, And then I think off to the races in Regular Session.
      Bullish
      👍️0
      MiamiGent MiamiGent 5 months ago
      $ARQT Tight Bid and ASK now.
      Getting serious.
      Bid ARCX
      10.55 x 10
      Ask XNMS
      10.59 x 1
      Volume
      2,437,578
      Bullish
      👍️0
      MiamiGent MiamiGent 5 months ago
      $ARQT
      Arcutis Biotherapeutics Inc

      I told ya!
      Currently in AH
      Bid XNMS 10.50 x 13
      Ask ARCX 10.67 x 20
      Volume
      2,429,849
      Bullish
      👍️0
      MiamiGent MiamiGent 5 months ago
      $ARQT New traders: Look at those big $10.48 buys!
      The few that follow are "paint jobs"- shorts trying to paint weakness.
      Pay attention to the big buys!
      $ARQT
      18:07:49 $10.41 5 paint job
      18:07:49 $10.35 20 paint job
      18:07:45 $10.48 15 paint job
      18:07:25 $10.48 7,900 real buy
      18:07:25 $10.48 1,500 real buy
      18:07:01 $10.3567 30
      18:05:44 $10.49 115
      18:04:57 $10.49 9,400
      18:04:26 $10.4887 110
      18:03:38 $10.42 6,212
      18:03:38 $10.42 2,200
      Bullish
      👍️0
      MiamiGent MiamiGent 5 months ago
      ARQT Arcutis Biotherapeutics' Zoryve Gets US FDA Approval!
      👍️0
      Sierra20 Sierra20 5 months ago
      I hope it will be approved. I think it will be approved. It’s just weird.
      👍️0
      MiamiGent MiamiGent 5 months ago
      You're being unnecessarily doomsdayish, Sierra.

      Fact is FDA has not announced re any candidates since July 3rd. There's an American holiday on the 4th (Thursday) and folks often take the next day off to make it a four-day break with only one vacation day used.
      Hope the weather is not as hot in Albania or wherever it is you plot your short plays and bashing.
      MG
      👍️0
      Sierra20 Sierra20 5 months ago
      CRL more than likely. I knew it. F! This is horrible!!!!
      https://investors.arcutis.com/news-releases/news-release-details/arcutis-provides-update-snda-roflumilast-cream-015-atopic/
      👍️0
      Sierra20 Sierra20 5 months ago
      They got CRL. 😔
      There’s no other reason for this delay. Back to $5 I think.
      👍️0
      Sierra20 Sierra20 5 months ago
      I think they are talking to fda to figure out what they needed to do to address the fda’s concerns before giving a pr about CRL.
      👍️0
      MiamiGent MiamiGent 5 months ago
      ARQT Only 40 more minutes for FDA to announce today.
      One time it did at 11:30 PM and it was a QUADRUPLE!
      👍️0
      MiamiGent MiamiGent 5 months ago
      You must be short. There's no basis for what you are saying.
      👍️0
      MiamiGent MiamiGent 5 months ago
      AQRT I'm in today.
      👍️0
      Sierra20 Sierra20 5 months ago
      CRL coming at 4 pm est. imo.
      👍️0
      Sierra20 Sierra20 5 months ago
      I think CRL coming…
      👍️0
      Sierra20 Sierra20 5 months ago
      Run
      👍️0
      52172 52172 5 months ago
      Havent missed nothing yet!
      👍️0
      52172 52172 5 months ago
      Monday boom!
      👍️0
      Sierra20 Sierra20 5 months ago
      I have the worst luck. I miss all the PDUFA. If they get delayed should not be a problem.
      👍️0
      Sierra20 Sierra20 5 months ago
      Oh no!!!!!
      👍️0
      Sierra20 Sierra20 5 months ago
      CRL? Delayed? What’s going on?
      👍️0
      Monksdream Monksdream 5 months ago
      ARQT under$10
      👍️0
      52172 52172 5 months ago
      No one knows shit approval is imminent
      👍️0
      Sierra20 Sierra20 5 months ago
      Someone knows something sell off started. 😔
      👍️0
      Sierra20 Sierra20 5 months ago
      I hope they didn’t get a CRL. People are selling. Something is going on.
      👍️0
      52172 52172 5 months ago
      408k share buy ah’s nothing else needed to say!
      👍️0
      52172 52172 5 months ago
      20’s imminent mark this post
      👍️0
      52172 52172 7 months ago
      Load the boat easy money
      👍️0
      52172 52172 7 months ago
      Buy opp!
      👍️0
      52172 52172 7 months ago
      ER coming on the 14th might get a bump then data in july
      👍️0
      Monksdream Monksdream 7 months ago
      ARQT under $10
      👍️0

      Your Recent History

      NASDAQ
      ARQT
      Arcutis Biotherapeutics
      BIT
      TEN
      Tenaris
      BOV
      HYPE3
      HYPERA ON
      Delayed Upgrade Clock